BioStock: BiBB coming off strong first half of 2023

It has been an eventful start to the year for BiBBInstruments. While the standout moment was the FDA market clearance for EndoDrill GI, the Swedish medtech posted a number other key milestones that are sure to work as a springboard for the rest of the year. BioStock got in touch with BiBB’s CEO Fredrik Lindblad to learn more.

Read the interview with Fredrik Lindblad at biostock.se:

https://www.biostock.se/en/2023/08/bibb-coming-off-strong-first-half-of-2023/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/